“Human Genome Sciences said early Monday that its experimental drug to treat lupus was effective in its second big clinical trial, raising the chances that the first new treatment for the disease in more than 40 years will make it to market,” reports The New York Times. The new drug, called Benlysta succeeded in its first clinical trial in July “to almost everyone’s surprise” following several failed drug candidates from numerous companies. “The lupus community has waited for decades for one positive phase three trial of an investigative drug developed for lupus,” Dr. Joan T. Merrill, a lupus expert at the Oklahoma Medical Research Foundation and an investigator in the trial, said in a statement issued by Human Genome Sciences and GlaxoSmithKline. “Now we have two.”
Big Think spoke with AI expert Nick Jennings about the future of regulating fast-evolving AI.
By supplementing the "principle of marginal gains” with these practical steps, you’ll be well equipped for the journey towards excellence.
Quiet quitting, The Great Resignation, burnout: there are a ton of buzzwords to describe how modern work culture is broken. Now that we know what the problems are, how do we fix them? Tiffani Bova shares how employers can heal their relationship with their employees.